Protective effect of yacon leaves extract (Smallanthus sonchifolius (Poepp.) H. Rob) through antifibrosis, anti-inflammatory, and antioxidant mechanisms toward diabetic nephropathy

Wahyu Widowati , Rita Tjokropranoto, Philips Onggowidjaja, Hanna Sari Widya Kusuma, Cahyaning Riski Wijayanti, Meganita Marthania, Afif Yati, Rizal Rizal


Background and purpose: Diabetic nephropathy (DN) is a chronic kidney failure, which may lead to fatality. Mesangial cell proliferation, renal inflammation, stress oxidative, and fibrosis are involved in DN progression. Yacon leaves (Smallanthus sonchifolius (Poepp.) H. Rob.) contains large amounts of phenolic compounds and it has the ability to inhibit oxidative stress, inflammation, and fibrosis. Considering the potential of yacon leaves extract (YLE), it may be used for DN treatment. This research aimed to elucidate YLE’s potential as anti-DN through anti-inflammatory, antioxidant, and antifibrosis mechanisms.

Experimental approach: Mesangial cells were induced by glucose 20 mM for 5 days and treated with YLE concentrations as much as 5, 10, and 50 µg/mL. TGF-β1, TNF-α, and MDA levels were measured using the ELISA method. SMAD2, SMAD3, SMAD4, and SMAD7 gene expressions were analyzed using the qRT-PCR method.

Findings/Results: YLE at 5, 10, and 50 µg/mL could reduce the levels of TGF-β1, TNF-α, and MDA compared with the DN cells model. YLE could reduce gene expressions of SMAD2, SMAD3, and SMAD4 and increase SMAD7 expression.

Conclusion and implications: YLE potentially mitigated diabetic nephropathy through antifibrosis, anti-inflammatory, and antioxidant capacities.


Diabetic nephropathy; MDA; SMADs; TGF-β1; TNF-α; Yacon leaves extract.

Full Text:



Fernandez-Fernandez B, Ortiz A, Gomez-Guerrero C, Egido J. Therapeutic approaches to diabetic nephropathy-beyond the RAS. Nat Rev Nephrol. 2014;10(6):325-346. DOI: 10.1038/nrneph.2014.74.

Ding Y, Choi ME. Autophagy in diabetic nephropathy. J Endocrinol. 2015;224(1):R15-R30. DOI: 10.1530/JOE-14-0437.

Pálsson R, Patel UD. Cardiovascular complications of diabetic kidney disease. Adv Chronic Kidney Dis. 2014;21(3):273-280. DOI: 10.1053/j.ackd.2014.03.003.

Schlöndorff D, Banas B. The mesangial cell revisited: no cell is an island. J Am Soc Neprol. 2009;20(6):1179-1187. DOI: 10.1681/ASN.2008050549.

Alsaad KO, Herzenberg AM. Distinguishing diabetic nephropathy from other causes of glomerulosclerosis: an update. J Clin Pathol. 2007;60(1):18-26. DOI: 10.1136/jcp.2005.035592.

Goldfarb S, Ziyadeh FN. TGF-beta: a crucial component of the pathogenesis of diabetic nephropathy. Trans Am Clin Climatol Assoc. 2001;112:27-32.PMID: 11413780.

Sharma K, McGowan TA. TGF-beta in diabetic kidney disease: role of novel signaling pathways. Cytokine Growth Factor Rev. 2000;11(1-2):115-123. DOI: 10.1016/s1359-6101(99)00035-0.

Livingston MJ, Ding HF, Huang S, Hill JA, Yin XM, Dong Z. Persistent activation of autophagy in kidney tubular cells promotes renal interstitial fibrosis during unilateral ureteral obstruction. Autophagy. 2016;12(6):976-998. DOI: 10.1080/15548627.2016.1166317.

Hata A, Chen YG. TGF-β signaling from receptors to Smads. Cold Spring Harb Perspect Biol. 2016;8(9):a022061,1-32.DOI: 10.1101/cshperspect.a022061.

Lan HY, Chung ACK. Transforming growth factor-β and Smads. Contrib Nephrol. 2011;170:75-82. DOI: 10.1159/000324949.

Lan HY. Smads as therapeutic targets for chronic kidney disease. Kidney Res Clin Pract. 2012;31(1):4-11. DOI: 10.1016/j.krcp.2011.12.001.

Barreto DV, Barreto FC, Liabeuf S, Temmar M, Lemke HD, Tribouilloy C, et al. Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease. Kidney Int. 2010;77(6):550-556. DOI: 10.1038/ki.2009.503.

Lee BT, Ahmed FA, Hamm LL, Teran FJ, Chen CS, Liu Y, et al. Association of C-reactive protein, tumor necrosis factor-alpha, and interleukin-6 with chronic kidney disease. BMC Nephrol. 2015;16:77,1-6. DOI: 10.1186/s12882-015-0068-7.

Chow F, Ozols E, Nikolic-Paterson DJ, Atkins RC, Tesch GH. Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury. Kidney Int. 2004; 65(1):116-128. DOI: 10.1111/j.1523-1755.2004.00367.x.

Gaede P, Poulsen HE, Parving HH, Pedersen O. Double-blind, randomised study of the effect of combined treatment with vitamin C and E on albuminuria in type 2 diabetic patients. Diabet Med. 2001;18(9):756-760.DOI: 10.1046/j.0742-3071.2001.00574.x.

Prasad BRS, Sreenivasulu U, Durga T. Study of serum malondialdehyde levels in chronic renal failure patients: a hospital based study in Govt. general hospital, Anantapuramu, Andhra Pradesh. Int J Clin Biochem Res. 2020;7(1):138-141. DOI: 10.18231/j.ijcbr.2020.028.

Simonovska B, Vovk I, Andrensek S, Valentová K, Ulrichová J. Investigation of phenolic acids in yacon (Smallanthus sonchifolius) leaves and tubers. J Chromatogr A. 2003;1016(1):89-98. DOI: 10.1016/s0021-9673(03)01183-x.

Russo D, Malafronte N, Frescura D, Imbrenda G, Faraone I, Milella L. Antioxidant activities and quali-quantitative analysis of different Smallanthus sonchifolius [(Poepp. and Endl.) H. Robinson] landrace extracts. Nat Prod Res. 2015;29(17): 1673-1677. DOI: 10.1080/14786419.2014.990906.

Ermawati, Arfian N, Purwono S, Romi MM, Sari DCR. Ethanol extract of yacon leaves (Smallanthus sonchifolius) attenuates fibroblast and myofibroblast expansion in association with downregulation of TGF-β1 and snail mRNA expression in 5/6-subtotal nephrectomy model in mice. Malaysian J Med Health Sci. 2022;18(3):85-91

Widowati W, Tjokropranoto R, Wahyudianingsih R, Tih F, Sadeli L, Kusuma HSW, et al. Antidiabetic potential yacon (Smallanthus sonchifolius (Poepp.) H. Rob.) leaf extract via antioxidant activities, inhibition of α-glucosidase, α-amylase, g-6-pase by in vitro assay. J Rep Pharm Sci. 2021; 10(2):247-255. DOI: 10.4103/jrptps.JRPTPS_3_21.

Abudayyak M, Gurkaynak TA, Ozhan G. In vitro evaluation of the toxicity of cobalt ferrite nanoparticles in kidney cell. Turk J Pharm Sci. 2017;14(2):169-173. DOI: 10.4274/tjps.99609.

Emilia O, Ulrika K, Petter S, Rashmi BP, Nikolay O, Emma A, et al. Glucose-induced changes in gene expression in human pancreatic islets: causes or consequences of chronic hyperglycemia. Diabetes. 2017;66(12):3013-3028.DOI: 10.2337/db17-0311.

Martinez-Oliveira P, Zuravski L, de Oliveira MF, Ströher DJ, Coelho RP, Pilar BC, et al. Evaluation in vitro of toxicity of hydroalcoholic extract of leaves and roots from yacon (Smallanthus sonchifolius). J Med Food. 2020;24(6):660-665. DOI: 10.1089/jmf.2020.0131.

Prahastuti S, Hidayat M, Hasiana ST, Widowati W, Amalia A, Qodariah RL, et al. Ethanol extract of detam 1 soybean seed (Glycine max L. Merr) for chronic kidney disease therapy by in vitro study. Trad Med J. 2019;24(3):160-168. DOI: 10.22146/mot.45053.

Prahastuti S, Hidayat SPM, Hasiana ST, Widowati W, Amalia A, Qodariah RL, et al. Ethanol extract of jati belanda (Guazuma ulmifolia L.) as therapy for chronic kidney disease in in vitro model. J Rep Pharma Sci. 2019;8(2):229-235.DOI: 10.4103/jrptps.JRPTPS_41_18.

Widowati W, Prahastuti S, Tjokropranoto R, Onggowidjaja P, Kusuma HSW, Afifah E, et al. Quercetin prevents chronic kidney disease on mesangial cells model by regulating inflammation, oxidative stress, and TGF-1/SMADs pathway. Peer J. 2022;10:e13257,1-16.DOI: 10.7717/peerj.13257.

Widowati W, Prahastuti S, Hidayat M, Hasianna ST, Aviani JK, Eltania TF, et al. Detam 1 black soybean against cisplatin-induced acute ren failure on rat model via antioxidant, antiinflammatory and antiapoptosis potential. J Trad Complement Med. 2022;12(4):426-435. DOI: 10.1016/j.jtcme.2022.01.004.

Ferraz APCR, Garcia JL, Costa MR, Almeida CCV, Gregolin CS, Alves PHR, et al. Yacon (Smallanthus sonchifolius) use as an antioxidant in diabetes. In: Preedy VR, editor. Pathology: oxidative stress and dietary antioxidants. London, United Kingdom: Academic Press; 2020. pp: 379-386. DOI: 10.1016/B978-0-12-815972-9.00036-6

Warren A, Knudsen ST, Cooper ME. Diabetic nephropathy: an insight into molecular mechanisms and emerging therapies. Expert Opin Ther Targets. 2019;23(7):579-591. DOI: 10.1080/14728222.2019.1624721.

Chen F, Wei G, Xu J, Ma X, Wang Q. Naringin ameliorates the high glucose-induced rat mesangial cell inflammatory reaction by modulating the NLRP3 inflammasome. BMC Complement Altern Med. 2018;18(1):192,1-11. DOI: 10.1186/s12906-018-2257-y.

Giera M, Lingeman H, Niessen WM. Recent advancements in the LC- and GC-based analysis of malondialdehyde (MDA): a brief overview. Chromatographia. 2012;75(9-10):433-440. DOI: 10.1007/s10337-012-2237-1.

Hachkova H, Nagalievska M, Soliljak Z, Kanyuka O, Kucharska AZ, Sokol-ketowska A, et al. Medicinal plants Galega officinalis L. and yacon leaves as potential sources of antidiabetic drugs. Antioxidants (Basel). 2021;10(9):1362,1-17. DOI: 10.3390/antiox10091362.

Calle P, Hotter G. Macrophage phenotype and fibrosis in diabetic nephropathy: review. Int J Mol Sci. 2020;21(8):2806,1-14. DOI: 10.3390/ijms21082806.

Massagué J. TGFβ signalling in context. Nat Rev Mol Cell Biol. 2012;13(10):616-630. DOI: 10.1038/nrm3434.

Macias MJ, Martin-Malpartida P, Massagué J. Structural determinants of Smad function in TGF-β signaling. Trends Biochem Sci. 2015;40(6): 296-308. DOI: 10.1016/j.tibs.2015.03.012.

Yan X, Liao H, Cheng M, Shi X, Lin X, Feng XH, et al. Smad7 protein interacts with receptor-regulated Smads (R-Smads) to inhibit transforming growth factor-β (TGF-β)/Smad signaling. J Biol Chem. 2016;291(1):382-392. DOI: 10.1074/jbc.M115.694281.

Honore SM, Carbera WM, Genta SB, Sanchez SS. Protective effect of yacon leaves decoction against early nephropathy experimental diabetic rats. Food Chem Toxicol. 2012;50(12):1704-1715. DOI: 10.1016/j.fct.2012.02.073.

Prahastuti S, Hidayat M, Hasiana ST, Widowati W, Widodo WS, Handayani AS, et al. The ethanol extract of the bastard cedar (Guazuma ulmifolia L.) as antioxidants. Pharmaciana. 2020;10(1):77-88. DOI: 10.12928/pharmaciana.v10i1.13636.

Widowati W, Prahastuti S, Ekayanti NLH, Munshy UZ, Kusuma HSW, Wibowo SHB, et al. Anti-inflammation assay of black soybean extract and its compounds on lipopolysaccharide-induced RAW 264.7 cell. J Phys Conf Ser. 2019;1374:1-11. DOI: 10.1088/1742-6596/1374/1/012052.


  • There are currently no refbacks.

Creative Commons LicenseThis work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.